Theresa L Davis

Array ( [id] => 961131 [patent_doc_number] => 06951844 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-04 [patent_title] => 'Phenyl naphthol ligands for thyroid hormone receptor' [patent_app_type] => utility [patent_app_number] => 10/946162 [patent_app_country] => US [patent_app_date] => 2004-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10933 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 508 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/951/06951844.pdf [firstpage_image] =>[orig_patent_app_number] => 10946162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 779291 [patent_doc_number] => 06995159 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-02-07 [patent_title] => '5-HT receptor ligands and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/942345 [patent_app_country] => US [patent_app_date] => 2004-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28319 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/995/06995159.pdf [firstpage_image] =>[orig_patent_app_number] => 10942345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7206804 [patent_doc_number] => 20050043313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade' [patent_app_type] => utility [patent_app_number] => 10/940693 [patent_app_country] => US [patent_app_date] => 2004-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 108005 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043313.pdf [firstpage_image] =>[orig_patent_app_number] => 10940693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 711631 [patent_doc_number] => 07057043 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-06 [patent_title] => 'Processes for preparing aminophenylsulfonylureas, and intermediates therefor' [patent_app_type] => utility [patent_app_number] => 10/936180 [patent_app_country] => US [patent_app_date] => 2004-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6909 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/057/07057043.pdf [firstpage_image] =>[orig_patent_app_number] => 10936180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6906208 [patent_doc_number] => 20050101603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Compound and method for the treatment of pain' [patent_app_type] => utility [patent_app_number] => 10/934753 [patent_app_country] => US [patent_app_date] => 2004-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6228 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101603.pdf [firstpage_image] =>[orig_patent_app_number] => 10934753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6972319 [patent_doc_number] => 20050038029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs' [patent_app_type] => utility [patent_app_number] => 10/930901 [patent_app_country] => US [patent_app_date] => 2004-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17701 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20050038029.pdf [firstpage_image] =>[orig_patent_app_number] => 10930901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 676728 [patent_doc_number] => 07087778 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-08 [patent_title] => 'Process for producing benzoxazine derivative and production intermediate thereof' [patent_app_type] => utility [patent_app_number] => 10/922832 [patent_app_country] => US [patent_app_date] => 2004-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32616 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/087/07087778.pdf [firstpage_image] =>[orig_patent_app_number] => 10922832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7026823 [patent_doc_number] => 20050020604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => '5-HT receptor ligands and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/922198 [patent_app_country] => US [patent_app_date] => 2004-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40471 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020604.pdf [firstpage_image] =>[orig_patent_app_number] => 10922198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6991466 [patent_doc_number] => 20050090503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => '5-HT receptor ligands and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/922058 [patent_app_country] => US [patent_app_date] => 2004-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40513 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090503.pdf [firstpage_image] =>[orig_patent_app_number] => 10922058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 925715 [patent_doc_number] => 07317013 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-08 [patent_title] => 'Cyclic pyrazinoylguanidine sodium channel blockers' [patent_app_type] => utility [patent_app_number] => 10/920353 [patent_app_country] => US [patent_app_date] => 2004-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20189 [patent_no_of_claims] => 173 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/317/07317013.pdf [firstpage_image] =>[orig_patent_app_number] => 10920353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 701899 [patent_doc_number] => 07064129 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-20 [patent_title] => 'Capped pyrazinoylguanidine sodium channel blockers' [patent_app_type] => utility [patent_app_number] => 10/920410 [patent_app_country] => US [patent_app_date] => 2004-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21579 [patent_no_of_claims] => 107 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/064/07064129.pdf [firstpage_image] =>[orig_patent_app_number] => 10920410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 856848 [patent_doc_number] => 07375107 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-20 [patent_title] => 'Alaphatic pyrazinoylguanidine sodium channel blockers' [patent_app_type] => utility [patent_app_number] => 10/920418 [patent_app_country] => US [patent_app_date] => 2004-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19646 [patent_no_of_claims] => 178 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/375/07375107.pdf [firstpage_image] =>[orig_patent_app_number] => 10920418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 830212 [patent_doc_number] => 07399766 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-15 [patent_title] => 'Soluble amide & ester pyrazinoylguanidine sodium channel blockers' [patent_app_type] => utility [patent_app_number] => 10/920391 [patent_app_country] => US [patent_app_date] => 2004-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27695 [patent_no_of_claims] => 152 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/399/07399766.pdf [firstpage_image] =>[orig_patent_app_number] => 10920391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 914647 [patent_doc_number] => 07326706 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-05 [patent_title] => 'Pyrazine modulators of cannabinoid receptors' [patent_app_type] => utility [patent_app_number] => 10/917199 [patent_app_country] => US [patent_app_date] => 2004-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16318 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/326/07326706.pdf [firstpage_image] =>[orig_patent_app_number] => 10917199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7163415 [patent_doc_number] => 20050085484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity' [patent_app_type] => utility [patent_app_number] => 10/915696 [patent_app_country] => US [patent_app_date] => 2004-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28551 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085484.pdf [firstpage_image] =>[orig_patent_app_number] => 10915696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 386682 [patent_doc_number] => 07304051 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-04 [patent_title] => 'Quinoxaline compounds' [patent_app_type] => utility [patent_app_number] => 10/910925 [patent_app_country] => US [patent_app_date] => 2004-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31949 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/304/07304051.pdf [firstpage_image] =>[orig_patent_app_number] => 10910925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 404818 [patent_doc_number] => 07288651 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-30 [patent_title] => 'Preparation of quinoxaline compounds' [patent_app_type] => utility [patent_app_number] => 10/910983 [patent_app_country] => US [patent_app_date] => 2004-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31953 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/288/07288651.pdf [firstpage_image] =>[orig_patent_app_number] => 10910983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5179682 [patent_doc_number] => 20070051023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Display assembly for laminar objects' [patent_app_type] => utility [patent_app_number] => 10/566430 [patent_app_country] => US [patent_app_date] => 2004-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3059 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20070051023.pdf [firstpage_image] =>[orig_patent_app_number] => 10566430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5662171 [patent_doc_number] => 20060252767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Piperazine derivatives and their use as therapeutic agents' [patent_app_type] => utility [patent_app_number] => 10/567009 [patent_app_country] => US [patent_app_date] => 2004-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21770 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252767.pdf [firstpage_image] =>[orig_patent_app_number] => 10567009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7435122 [patent_doc_number] => 20040266764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Hydroxamic acid derivatives' [patent_app_type] => new [patent_app_number] => 10/902753 [patent_app_country] => US [patent_app_date] => 2004-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16910 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266764.pdf [firstpage_image] =>[orig_patent_app_number] => 10902753 [rel_patent_id] =>[rel_patent_doc_number] =>)